Members of the WHO Guidelines Development Group recently attempted to provide worldwide “evidence-based recommendations” for the prevention of surgical site infections (SSI) by stating:
Adult patients undergoing general anaesthesia with endotracheal intubation for surgical procedures should receive 80% fraction of inspired oxygen intraoperatively and, if feasible, in the immediate postoperative period for 2–6 h [1].
This explicit and strong recommendation has caused considerable concern in the anaesthesia community because it directly contradicts the results of many trials (and a meta-analysis of those trials) which showed no benefit of supplemental oxygen.
The use of an increased inspired oxygen fraction (FiO2) has a long history in anaesthesia, intensive care, and emergency medicine. Planned induction and extubation of anaesthesia are conducted with 100% oxygen to enhance safety in the case of airway difficulty. Extra oxygen is also given during general anaesthesia as 21% is rarely sufficient, with concentrations ranging from 30% to nearly 100% depending on case factors and anaesthesiologist preference.
There is considerable reason to expect that supplemental oxygen might reduce the risk of surgical site infection [21]. All surgical wounds become contaminated, and the primary defence against bacterial contamination is oxidative killing by neutrophils, a process that requires molecular oxygen and depends on the partial pressure of oxygen in tissue over the entire physiological range. Consistent with this theory, Hopf et al. [11] showed that surgical wound infection risk was inversely related to tissue oxygenation. Based on these observational data, the Outcomes Research Consortium randomized 500 patients having colorectal resection to either 80% or 30% inspired oxygen [9]. The incidence of SSI was halved from 11.2% to 5.2% (p = 0.001). The next study was a small methodologically weak trial in a broader surgical population which reported that infection risk was more than doubled in patients given supplemental oxygen (25% vs. 11.3%, p < 0.02 [20]). These studies prompted many others. So far, there have been 6 published trials with 3265 patients reporting positive results with increased FiO2 [3, 4, 9, 14, 17, 22]. On the other hand 7 trials including 2992 patients reported no benefit of 80% inspired oxygen (Table 1) [2, 12, 13, 15, 20, 26, 28].
The WHO panel members based their recommendations on a meta-analysis of 11 randomized trials of supplemental oxygen during and after general anaesthesia. Using a random effects model, they estimated the odds ratio (OR) for SSI as 0.72 (95% confidence interval CI; 0.55–0.94) in favour of 80% inspired oxygen; however, it is quite unclear why the WHO panel excluded studies by Kurz et al. [12] and Anthony et al. [2]. The question is critical because including the results of Kurz et al. [12] and Anthony et al. [2] in the meta-analysis (using the same methodology) yields an OR of 0.84 (CI: 0.62–1.12, p = 0.242), a value that no longer supports this panel’s recommendation.
We and the WHO panellists recognize that “ventilation control (and therefore the actual administration of FiO2) with a face mask or nasal cannulae in neuraxial anaesthesia (differs) from mechanical ventilation” [1]. But to the extent that increased FiO2 protects against wound infection, it should also do so during regional anaesthesia (for example in caesarean deliveries). There are currently 4 randomized controlled reports of 1769 parturients randomized to receive either 80% or 30% inspired oxygen during regional anaesthesia and for 1–2 h thereafter. None of the trials from Seattle [8], St. Louis [24], San Jose [6] and Dayton [9] found that supplemental oxygen reduced infection risk. There is thus not a single trial providing any evidence supporting the recommendation to increase FiO2 during regional anaesthesia. Including regional anaesthesia studies in the meta-analysis of all available trials in women yields an OR of 0.93 (95% CI: 0.72–1.2, see Fig. 1).
We also note that high inspired oxygen fractions may not be entirely harmless, at least in non-operative contexts. Hyperoxaemia-induced vasoconstriction may be dangerous in patients with critical coronary stenosis [29] and ST-elevation myocardial infarction [27]. The international liaison committee on resuscitation no longer supports the use of supplemental oxygen as long as peripheral saturation (SpO2) is >94% [18]. Several meta-analyses [5, 19] concluded that hyperoxaemia may be associated with increased mortality in patients with stroke, traumatic brain injury, and those resuscitated after cardiac arrest. Supplemental oxygen may be associated with increased mortality after emergency admissions [25]. Finally, there is mechanistic evidence that high inspired oxygen fractions may be harmful, for example in patients with chronic obstructive pulmonary disease, impaired hypoxic ventilatory drive, or lung failure [10]. Whether supplemental perioperative oxygen is dangerous is much less obvious but Fonnes et al. [7] reanalysed patients randomized in the PROXI trial and found that acute coronary syndrome was nearly twice as common in patients given 80% inspired oxygen. Mortality, despite an initial report [16], appears to be unaffected by supplemental oxygen [19].
The WHO Guidelines Development Group, which curiously included no anaesthesiologists, did not consider all relevant data in their analysis. When all data are included, the results are clear: supplemental oxygen does not reduce wound infection risk. The WHO recommendations, based on selective data, contradict the totality of available evidence and thus fail to provide useful guidance. We recommend that anaesthesiologists base their selection of inspired oxygen concentration on considerations other than wound infection risk.
T. Volk
J. Peters
D. I. Sessler
References
Allegranzi B, Zayed B, Bischoff P et al (2016) New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis 16(12):e288–e303
Anthony T, Murray BW, Sum-Ping JT et al (2011) Evaluating an evidence-based bundle for preventing surgical site infection: a randomized trial. Arch Surg 146:263–269
Belda FJ, Aguilera L, de la García Asunción J et al (2005) Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 294(16):2035–2042
Bickel A, Gurevits M, Vamos R et al (2011) Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis: a randomized, prospective, controlled trial. Arch Surg 146(4):464–470
Damiani E, Adrario E, Girardis M et al (2014) Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis. Crit Care 18(6):711
Duggal N, Poddatoori V, Noroozkhani S et al (2013) Perioperative oxygen supplementation and surgical site infection after cesarean delivery: a randomized trial. Obstet Gynecol 122:79–84
Fonnes S, Gögenur I, Søndergaard ES et al (2016) Perioperative hyperoxia – Long-term impact on cardiovascular complications after abdominal surgery, a post hoc analysis of the PROXI trial. Int J Cardiol 15(215):238–243
Gardella C, Goltra LB, Laschansky E et al (2008) High-concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstet Gynecol 112:545–552
Greif R, Akça O, Horn EP et al (2000) Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med 342(3):161–167
Helmerhorst HJ, Roos-Blom MJ, van Westerloo DJ et al (2015) Association between arterial hyperoxia and outcome in subsets of critical illness: a systematic review, meta-analysis, and meta-regression of cohort studies. Crit Care Med 43(7):1508–1519
Hopf HW, Hunt TK, West JM et al (1997) Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 132:997–1005
Kurz A, Fleischmann E, Sessler DI et al (2015) Effects of supplemental oxygen and dexamethasone on surgical site infection: a factorial randomized trial. Br J Anaesth 115:434–443
Mayzler O, Weksler N, Domchik S et al (2005) Does supplemental perioperative oxygen administration reduce the incidence of wound infection in elective colorectal surgery? Minerva Anestesiol 71(1–2):21–25
Myles PS, Leslie K, Chan MT et al (2007) Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology 107(2):221–231
Meyhoff CS, Wetterslev J, Jorgensen LN et al (2009) Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA 302(14):1543–1550
Meyhoff CS, Jorgensen LN, Wetterslev J et al (2012) Increased long-term mortality after a high perioperative inspiratory oxygen fraction during abdominal surgery: follow-up of a randomized clinical trial. Anesth Analg 115:849–854
Meyhoff CS, Jorgensen LN, Rasmussen LS et al (2015) High oxygen concentration to prevent surgical site infection after rectal cancer surgery. Am J Surg 209(4):771
Nikolaou NI, Arntz HR, Bellou A et al (2015) European Resuscitation Council Guidelines for Resuscitation 2015 Section 8. Initial management of acute coronary syndromes. Resuscitation 95:264–277
Podolyak A, Sessler DI, Reiterer C et al (2016) Perioperative supplemental oxygen does not worsen long-term mortality of colorectal surgery patients. Anesth Analg 122:1907–1911
Pryor KO, Fahey TJ 3rd, Lien CA et al (2004) Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA 291(1):79–87
Scheithauer S, Artelt T, Bauer M et al (2016) Prevention of postoperative surgical site infections: Between tradition and evidence. Anaesthesist 65(5):328–336
Schietroma M, Cecilia EM, Carlei F, al at (2013) Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double-blind, controlled, single-center trial. Ann Surg Oncol 20(5):1584–1590
Schietroma M, Cecilia EM, Sista F et al (2014) High-concentration supplemental perioperative oxygen and surgical site infection following elective colorectal surgery for rectal cancer: a prospective, randomized, double-blind, controlled, single-site trial. Am J Surg 208(5):719–726
Scifres CM, Leighton BL, Fogertey PJ et al (2011) Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. Am J Obstet Gynecol 205(3):267.e1–267.e9
Smith GB, Prytherch DR, Watson D et al (2012) S(p)O(2) values in acute medical admissions breathing air-implications for the British Thoracic Society guideline for emergency oxygen use in adult patients? Resuscitation 83:1201–1205
Stall A, Paryavi E, Gupta R et al (2013) Perioperative supplemental oxygen to reduce surgical site infection after open fixation of high-risk fractures: a randomized controlled pilot trial. J Trauma Acute Care Surg 75(4):657–663
Stub D, Smith K, Bernard S et al (2015) Air versus oxygen in ST-segment-elevation myocardial infarction. Circulation 131(24):2143–2150
Thibon P, Borgey F, Boutreux S et al (2012) Effect of perioperative oxygen supplementation on 30-day surgical site infection rate in abdominal, gynecologic, and breast surgery: the ISO 2 randomized controlled trial. Anesthesiology 117(3):504–511
Wijesinghe M, Perrin K, Ranchord A et al (2009) Routine use of oxygen in the treatment of Myocardial infarction: systematic review. Heart 95:198–202
Williams NL, Glover MM, Crisp C et al (2013) Randomized controlled trial of the effect of 30 % versus 80 % fraction of inspired oxygen on cesarean delivery surgical site infection. Am J Perinatol 30:781–786
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
T. Volk, J. Peters and D. I. Sessler declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Volk, T., Peters, J. & Sessler, D.I. The WHO recommendation for 80% perioperative oxygen is poorly justified. Anaesthesist 66, 227–229 (2017). https://doi.org/10.1007/s00101-017-0286-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-017-0286-4